US FDA grants fast track designation to Rznomics’ gene therapy-based cancer drug candidate, RZ-001: Seongnam, South Korea Wednesday, February 19, 2025, 16:00 Hrs [IST] Rznomics, ...
The US FDA has granted fast track designation to Rznomics' RZ-001 for the treatment of hepatocellular carcinoma (HCC).
The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...
Represents costs recorded to Other operating expense (income), net incurred in connection with the separation of BD's former Diabetes Care business. BioArctic AB's (publ) partner Eisai has ...
Restaurant menus that show calorie counts can harm people with eating disorders The calorie labels can reinforce unhealthy thoughts and beliefs related to eating disorders They also can cause ...